InMed Pharmaceuticals Inc (INM) Stock Price & News

All values in USD	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	820.19K	-	-	-
Cost of goods sold	635.99K	-	-	-
Cost of revenue	635.99K	-	-	-
Research and development expenses	630.64K	1.02M	805.74K	206.02K
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.62M	1.74M	2.36M	1.80M
Operating expense	2.30M	2.82M	3.21M	2.01M
Total operating expenses	2.94M	2.82M	3.21M	2.01M
Operating income	-2.12M	-2.82M	-3.21M	-2.01M
Other non operating income	-	-	-	-
EBT including unusual items	-2.03M	-2.79M	-4.84M	-2.00M
EBT excluding unusual items	-2.03M	-2.79M	-3.19M	-2.00M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-2.03M	-2.97M	-5.84M	-2.33M
Net profit margin	-247.29%	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	74.38K	47.77K	29.06K	14.31K
Interest expense	-	-	-10.70K	-
Net interest expenses	74.38K	47.77K	18.36K	14.31K
Depreciation and amortization charges	53.20K	51.71K	48.36K	168.00
EBITDA	-2.07M	-2.77M	-3.16M	-2.01M
Gain or loss from assets sale	-	-	7.14K	-

Finance